Clinical Trial Update: An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States

View source ↗

Summary

Completed observational study sponsored by Bayer to identify new health problems arising after ICU admission in people with acute respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-intensive Care Syndrome
• Respiratory Distress Syndrome

Snippet

Sponsor: Bayer | Conditions: Acute Respiratory Distress Syndrome (ARDS), Post Intensive Care Syndrome (PICS) | Status: COMPLETED